Sarah Weiser

Sarah Weiser Senior Principal Scientist – Group Leader Pfizer, Inc. After working for several years in a clinical setting, Sarah joined Pfizer (Wyeth) in 2007 as part of BioTherapeutics Pharmaceutical R&D in Andover, MA. Sarah has lead or contributed to drug product development programs from pre-clinical through BLA and commercial line extensions, including combination products. Sarah was the drug product handling lead for the Pfizer BioNTech Covid-19 vaccine and helped develop the global last-mile storage and transportation strategy. In her current role, she leads a team which oversees design and development of dosing and administration instructions for Pfizer’s sterile parenteral portfolio from clinical to commercial, and is the SME for in-use stability and compatibility issues, product design, commercial product labeling, and regulatory requirements in this area.

Appearances